24.07.2014 - Shares of Valeant Pharmaceuticals International can leave the triangle

The stock price of Valeant Pharmaceuticals International continues to fall along the upper boundary of the triangle. In case of continued downward trend a signal to sell with the objectives of 100.00 and 92.00 will be the price fixing below 117.00. Break through the upper boundary of the triangle and fixing the prices higher than 128.85, which is the nearest local maximum will confirm the signal to buy shares of the company with growth potential up to 30%. We recommend to wait for new signals for opening positions.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.